Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136682

Published: 2020

Journal Articles

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Leonardo R. Brandao, MD, Igor Tartakovsky, MD, Manuela Albisetti, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Matteo Luciani, MD, Paola Saracco, MD, Judy Felgenhauer, MD, Olga Lvova, MD, Monika Simetzberger, DI, Zhichao Sun, PhD, Ingrid Gergei, MD, Martina Brueckmann, MD, Jacqueline Halton, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136695

Published: 2020

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

C. Michel Zwaan, MD PhD, Stefan Söderhäll, MD PhD, Benoit Brethon, MD, Matteo Luciani, MD, Carmelo Rizzari, MD, David Sternberg, MD PhD, Emmanuelle Besse, Catherine Dutreix, MD, Franca Fagioli, MD, Phoenix Ho, MD, Carlo Dufour, MD, Rob Pieters, MD PhD

Blood (2015) 126 (23): 2564.

https://doi.org/10.1182/blood.V126.23.2564.2564

Published: 2015

Journal Articles

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Concetta Micalizzi, MD, Rosanna Parasole, Maria Caterina Putti, MD, Matteo Luciani, MD, Laura Banov, MD, Fara Petruzziello, Chiara Messina, Giulio De Rossi

Blood (2008) 112 (11): 3953.

https://doi.org/10.1182/blood.V112.11.3953.3953

Published: 2008

Journal Articles

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Matteo Luciani, MD, Valeria Pansini, MD, Valentina Coletti, MD, Daria Funaro, MD, Massimiliano Soldati, MD, Simona Pancotti, Piergiorgio Falappa, MD, Giulio De Rossi, MD

Blood (2008) 112 (11): 5357.

https://doi.org/10.1182/blood.V112.11.5357.5357

Published: 2008

Journal Articles

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Elena Santagostino, MD, PhD, Angiola Rocino, MD, Maria E. Mancuso, MD, Maria G. Mazzucconi, MD, Giacomo Mancuso, MD, Maria Messina, MD, Annarita Tagliaferri, MD, Matteo Luciani, MD, Elio Boeri, MD, Pier M. Mannucci, MD

Blood (2004) 104 (11): 37.

https://doi.org/10.1182/blood.V104.11.37.37

Published: 2004

Journal Articles

High Clonal Evolution Rate in Relapsing Infant ALL Patients.

Giovanni Cazzaniga, PhD, Lilia Corral, BSc, Matteo Luciani, MD, Simona Songia, Bsc, Paola De Lorenzo, PhD, Monica Spinelli, PhD, Luca Lo Nigro, MD, Giuseppe Basso, MD, Giulio De Rossi, MD, Andrea Biondi, MD

Blood (2004) 104 (11): 164.

https://doi.org/10.1182/blood.V104.11.164.164

Published: 2004

NARROW

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

High Clonal Evolution Rate in Relapsing Infant ALL Patients.

Email alerts

ASH Publications

American Society of Hematology

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

High Clonal Evolution Rate in Relapsing Infant ALL Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only